Erifili Hatziagelaki
National and Kapodistrian University of Athens
64 Papers
382 Citations
Erifili Hatziagelaki is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Medicine & Diabetes mellitus. The author has an hindex of 21, co-authored 62 publications. Previous affiliations of Erifili Hatziagelaki include Tufts University & Athens State University.
Chat about Author
Papers
Subcutaneous glucose monitoring with GlucoDay: comparison of the results to those obtained with the endocrine artificial pancreas.
George Dimitriadis,Eleni Boutati,A. E. Raptis,Erifili Hatziagelaki,Panayota Mitrou,Vaia Lambadiari,Nikolaos Tountas,Theofanis Economopoulos,Sotirios A. Raptis +8 more
TL;DR: GlucoDay® is a reliable method for continuous glucose monitoring and may prove useful for optimizating treatment in patients with type 1 or type 2 diabetes.
SRC-3/AIB-1 may Enhance Hepatic NFATC1 Transcription and Mediate Inflammation in a Tissue-Specific Manner in Morbid Obesity.
Athina Chasapi,Konstantinos Balampanis,Anna Tanoglidi,Eleni Kourea,George I. Lambrou,Vaia Lambadiari,Fotios Kalfarentzos,Erifili Hatziagelaki,Maria Melachrinou,Georgia Sotiropoulou-Bonikou +9 more
TL;DR: A complex and extensive inter- and intra-tissue network among the three main investigated proteins and the inflammatory biomarkers is revealed, suggesting their participation in the obesity-induced inflammatory cascade.
1
Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Dimitrios Farmakis,Panagiotis Simitsis,Vasiliki Bistola,Filippos Triposkiadis,Ignatios Ikonomidis,Spyridon Katsanos,George Bakosis,Erifili Hatziagelaki,John Lekakis,Alexandre Mebazaa,John Parissis +10 more
TL;DR: Hospitalized HFmrEF patients represent a demographically and clinically diverse group with many intermediate features compared to HFrEF and HFpEF and carry a lower risk of short-term mortality than HFr EF but a similar risk withHFpEF.
Metabolic syndrome, independent of its components, affects adversely cardiovascular morbidity in essential hypertensives.
George Georgiopoulos,Costas Tsioufis,Dimitrios Tsiachris,Kyriakos Dimitriadis,Alexandros Kasiakogias,Fotini Lagiou,Eirini Andrikou,Ioannis Ioannidis,Erifili Hatziagelaki,Dimitris Tousoulis +9 more
TL;DR: Early identification of MS in this population may enable more accurate prediction of future cardiovascular risk and could implement more efficient strategies in terms of primary prevention.
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?
Erifili Hatziagelaki,Maria Adamaki,Irene Tsilioni,George Dimitriadis,Theoharis C. Theoharides +4 more
TL;DR: It is proposed that stimulation of hypothalamic mast cells by environmental, neuroimmune, pathogenic and stress triggers activates microglia, leading to focal inflammation in the brain and disturbed homeostasis, which could be targeted for the development of novel effective treatments.